In the last trading session, 2.78 million ZyVersa Therapeutics Inc (NASDAQ:ZVSA) shares changed hands as the company’s beta touched 0.42. With the company’s per share price at $0.08 changed hands at $0.0 or 8.20% during last session, the market valuation stood at $3.56M. ZVSA’s last price was a discount, traded about -31150.0% off its 52-week high of $25.00. The share price had its 52-week low at $0.07, which suggests the last value was 12.5% up since then. When we look at ZyVersa Therapeutics Inc’s average trading volume, we note the 10-day average is 7.41 million shares, with the 3-month average coming to 7.01 million.
Analysts gave the ZyVersa Therapeutics Inc (ZVSA) stock a consensus recommendation rating of a Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended ZVSA as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. ZyVersa Therapeutics Inc’s EPS for the current quarter is expected to be -$0.17.
ZyVersa Therapeutics Inc (NASDAQ:ZVSA) trade information
Instantly ZVSA was in green as seen at the end of in last trading. With action 23.38%, the performance over the past five days has been green. The jump to weekly highs of 0.0987 on Friday, 11/17/23 added 8.20% to the stock’s daily price. The company’s shares are showing year-to-date downside of -94.79%, with the 5-day performance at 23.38% in the green. However, in the 30-day time frame, ZyVersa Therapeutics Inc (NASDAQ:ZVSA) is -36.14% down. Looking at the short shares, we see there were 1.83 million shares sold at short interest cover period of 0.4 days.
ZyVersa Therapeutics Inc is expected to release its next quarterly earnings report in December.
ZyVersa Therapeutics Inc (NASDAQ:ZVSA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 54.44% of ZyVersa Therapeutics Inc shares while 27.97% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 61.38%. There are 27.97% institutions holding the ZyVersa Therapeutics Inc stock share, with Walleye Capital LLC the top institutional holder. As of Sep 29, 2023, the company held 3.17% of the shares, roughly 0.98 million ZVSA shares worth $80308.0.
Geode Capital Management, LLC holds the second largest percentage of outstanding shares, with 0.40% or 0.12 million shares worth $10084.0 as of Sep 29, 2023.
Among Mutual Funds, the top two as of Jun 29, 2023 were Vanguard Extended Market Index Fund and Fidelity NASDAQ Composite Index Fund. With 17194.0 shares estimated at $1408.0 under it, the former controlled 0.06% of total outstanding shares. On the other hand, Fidelity NASDAQ Composite Index Fund held about 0.01% of the shares, roughly 4076.0 shares worth around $333.0.